Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Preferred Stock Liabilities (2022 - 2025)

Historic Preferred Stock Liabilities for Envoy Medical (COCH) over the last 3 years, with Q3 2025 value amounting to $130000.0.

  • Envoy Medical's Preferred Stock Liabilities changed N/A to $130000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $130000.0, marking a year-over-year change of. This contributed to the annual value of $429.7 million for FY2022, which is N/A changed from last year.
  • Per Envoy Medical's latest filing, its Preferred Stock Liabilities stood at $130000.0 for Q3 2025.
  • Over the past 5 years, Envoy Medical's Preferred Stock Liabilities peaked at $429.7 million during Q4 2022, and registered a low of $130000.0 during Q3 2025.
  • In the last 3 years, Envoy Medical's Preferred Stock Liabilities had a median value of $425.0 million in 2022 and averaged $256.5 million.
  • Examining YoY changes over the last 5 years, Envoy Medical's Preferred Stock Liabilities showed a top increase of 8951.41% in 2023 and a maximum decrease of 8960.8% in 2023.
  • Quarter analysis of 3 years shows Envoy Medical's Preferred Stock Liabilities stood at $429.7 million in 2022, then tumbled by 89.62% to $44.6 million in 2023, then plummeted by 99.71% to $130000.0 in 2025.
  • Its Preferred Stock Liabilities stands at $130000.0 for Q3 2025, versus $44.6 million for Q2 2023 and $44.2 million for Q1 2023.